These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36593557)

  • 1. Epigenetic Regulation as a New Therapeutic Target for Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Hirabayashi M; Shimmura H; Kojima H
    Otol Neurotol; 2023 Mar; 44(3):273-280. PubMed ID: 36593557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menin-MLL inhibitor blocks progression of middle ear cholesteatoma in vivo.
    Yamamoto-Fukuda T; Akiyama N; Tatsumi N; Okabe M; Kojima H
    Int J Pediatr Otorhinolaryngol; 2021 Jan; 140():110545. PubMed ID: 33302022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescent photoimmunoconjugate for imaging of cholesteatoma.
    Early S; Saad MA; Mallidi S; Mansour A; Seist R; Hasan T; Stankovic KM
    Sci Rep; 2022 Nov; 12(1):19905. PubMed ID: 36402793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Kojima H
    J Assoc Res Otolaryngol; 2021 Jul; 22(4):405-424. PubMed ID: 33861394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Burow's solution treatment for external auditory canal and mastoid cavity cholesteatoma].
    Terayama Y; Sakata A; Murata Y; Harada K; Ohashi M
    Nihon Jibiinkoka Gakkai Kaiho; 2010 Jun; 113(6):549-55. PubMed ID: 20653194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of middle ear aeration on surgical outcome after intact canal wall tympanoplasty for cholesteatoma.
    Motegi M; Yamamoto Y; Ouchi K; Akutsu T; Tada T; Kurihara S; Takahashi M; Sampei S; Sano H; Morino T; Komori M; Yamamoto K; Sakurai Y; Kojima H
    Auris Nasus Larynx; 2020 Dec; 47(6):965-975. PubMed ID: 32646631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte Growth Factor (KGF) Modulates Epidermal Progenitor Cell Kinetics through Activation of p63 in Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Takahashi M; Kojima H
    J Assoc Res Otolaryngol; 2018 Jun; 19(3):223-241. PubMed ID: 29549594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of messenger RNA for keratinocyte growth factor in human cholesteatoma.
    Kojima H; Matsuhisa A; Shiwa M; Kamide Y; Nakamura M; Ohno T; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1996 Feb; 122(2):157-60. PubMed ID: 8630209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesteatoma: rare, but can have serious consequences].
    Timmer ML; Borggreven PA; van de Langenberg R; Quak JJ; Colnot DR
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KGFR as a possible therapeutic target in middle ear cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Shibata Y; Takahashi H; Ikeda T; Kohno M; Koji T
    Acta Otolaryngol; 2014 Nov; 134(11):1121-7. PubMed ID: 25315911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous meatal skin graft implantation and intratympanic injection of Pseudomonas aeruginosa: a new experimental mouse model of acquired middle ear cholesteatoma.
    Si Y; Chen YB; Chen QX; Liu Y; Jiang HL; Zhang ZG; Huang X
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(5):274-81. PubMed ID: 24030443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental middle ear cholesteatoma originated from free skin graft of the external ear].
    Hinohira Y
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Jun; 94(6):794-804. PubMed ID: 1886032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otologic effects of topical mitomycin C: phase I-evaluation of ototoxicity.
    Babu SC; Kartush JM; Patni A
    Otol Neurotol; 2005 Mar; 26(2):140-4. PubMed ID: 15793395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of external auricular cholesteatoma involving tympanum and papilloma].
    Song ZY; Yu XM; Wang CF; Wang N; Fu Y; Song YQ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 32(12):937-940. PubMed ID: 29921078
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesteatoma of the middle ear in human patients. An ultrastructural study.
    Schaper J; van de Heyning J
    Arch Otolaryngol; 1976 Nov; 102(11):663-8. PubMed ID: 985197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
    Yamamoto-Fukuda T; Akiyama N
    Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilute vinegar therapy for the management of spontaneous external auditory canal cholesteatoma.
    Chang J; Choi J; Im GJ; Jung HH
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):481-5. PubMed ID: 21739099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of patterns of disease extension in keratosis obturans and external auditory canal cholesteatoma.
    Shinnabe A; Hara M; Hasegawa M; Matsuzawa S; Kanazawa H; Yoshida N; Iino Y
    Otol Neurotol; 2013 Jan; 34(1):91-4. PubMed ID: 23235551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography features of middle ear cholesteatoma in dogs.
    Travetti O; Giudice C; Greci V; Lombardo R; Mortellaro CM; Di Giancamillo M
    Vet Radiol Ultrasound; 2010; 51(4):374-9. PubMed ID: 20806867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo over-expression of KGF mimic human middle ear cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Shibata Y; Takahashi H; Ikeda T; Koji T
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2689-96. PubMed ID: 25138153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.